These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27760764)

  • 1. BNP, troponin I, and YKL-40 as screening markers in extremely preterm infants at risk for pulmonary hypertension associated with bronchopulmonary dysplasia.
    König K; Guy KJ; Nold-Petry CA; Barfield CP; Walsh G; Drew SM; Veldman A; Nold MF; Casalaz DM
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1076-L1081. PubMed ID: 27760764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Brain Natriuretic Peptide for Diagnosing Pulmonary Hypertension in Severe Bronchopulmonary Dysplasia.
    Avitabile CM; Ansems S; Wang Y; Fraga MV; Kirpalani HM; Zhang H; Mercer-Rosa L; Jensen EA
    Neonatology; 2019; 116(2):147-153. PubMed ID: 31096210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide and mortality in extremely low birth weight infants with pulmonary hypertension: a retrospective cohort analysis.
    Cuna A; Kandasamy J; Sims B
    BMC Pediatr; 2014 Mar; 14():68. PubMed ID: 24612708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Screening for Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.
    Montgomery AM; Bazzy-Asaad A; Asnes JD; Bizzarro MJ; Ehrenkranz RA; Weismann CG
    Neonatology; 2016; 109(3):190-4. PubMed ID: 26780635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?
    Kalra VK; Aggarwal S; Arora P; Natarajan G
    Pediatr Pulmonol; 2014 Nov; 49(11):1106-11. PubMed ID: 24214578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715
    [No Abstract]   [Full Text] [Related]  

  • 7. NTproBNP as a surrogate biomarker for early screening of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
    Dasgupta S; Aly AM; Malloy MH; Okorodudu AO; Jain SK
    J Perinatol; 2018 Sep; 38(9):1252-1257. PubMed ID: 29977013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic peptides in bronchopulmonary dysplasia: a systematic review.
    Xiong T; Kulkarni M; Gokulakrishnan G; Shivanna B; Pammi M
    J Perinatol; 2020 Apr; 40(4):607-615. PubMed ID: 31925319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early cardiac function and death, severe bronchopulmonary dysplasia and pulmonary hypertension in extremely preterm infants.
    Moore SS; De Carvalho Nunes G; Dancea A; Wutthigate P; Simoneau J; Beltempo M; Sant'Anna G; Altit G
    Pediatr Res; 2024 Jan; 95(1):293-301. PubMed ID: 37726544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Terminal Pro-B Type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia or Death in Very Preterm Neonates: A Cohort Study.
    Sellmer A; Hjortdal VE; Bjerre JV; Schmidt MR; McNamara PJ; Bech BH; Henriksen TB
    PLoS One; 2015; 10(10):e0140079. PubMed ID: 26452045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening Echocardiography and Brain Natriuretic Peptide Levels Predict Late Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
    Behere S; Alapati D; McCulloch MA
    Pediatr Cardiol; 2019 Jun; 40(5):973-979. PubMed ID: 30937503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of BNP, NTproBNP, and early postnatal pulmonary hypertension in very preterm infants.
    König K; Guy KJ; Walsh G; Drew SM; Barfield CP
    Pediatr Pulmonol; 2016 Aug; 51(8):820-4. PubMed ID: 26969913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
    Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM
    J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental outcomes of preterm infants with bronchopulmonary dysplasia-associated pulmonary hypertension at 18-24 months of corrected age.
    Choi EK; Shin SH; Kim EK; Kim HS
    BMC Pediatr; 2019 Jan; 19(1):26. PubMed ID: 30654786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of pulmonary hypertension on neurodevelopmental outcome in preterm infants with bronchopulmonary dysplasia: a cohort study.
    Nakanishi H; Uchiyama A; Kusuda S
    J Perinatol; 2016 Oct; 36(10):890-6. PubMed ID: 27442157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
    Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH
    Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
    Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
    Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in serum human cartilage glycoprotein-39 and high-mobility group box 1 in preterm infants with bronchopulmonary dysplasia].
    Zhou Y; Meng LJ; Wang J
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Apr; 22(4):334-338. PubMed ID: 32312371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia.
    Alvarez-Fuente M; Moreno L; Lopez-Ortego P; Arruza L; Avila-Alvarez A; Muro M; Gutierrez E; Zozaya C; Sanchez-Helguera G; Elorza D; Martinez-Ramas A; Villar G; Labrandero C; Martinez L; Casado T; Cuadrado I; Del Cerro MJ
    PLoS One; 2019; 14(3):e0213210. PubMed ID: 30840669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.